Novonesis (Novozymes) B (FRA:NZM2)
€ 57.2 -0.14 (-0.24%) Market Cap: 26.58 Bil Enterprise Value: 28.31 Bil PE Ratio: 39.62 PB Ratio: 2.44 GF Score: 95/100

Q1 2021 Novozymes A/S Earnings Call Transcript

Apr 27, 2021 / 07:00AM GMT
Release Date Price: €59.78 (+5.99%)
Tobias Cornelius Bjorklund;S;Head of IR;Ester Baiget
Novozymes A;Novozymes A

/-

Good morning, everyone, and welcome to Novozymes First Quarter Conference Call. My name is Tobias Bjorklund, and I'm the Head of Investor Relations here at Novozymes.

At this call, our CEO, Ester Baiget; and our CFO, Lars Green, will review our performance for the first quarter and the outlook for the full year. Our executive team, including its 2 newest members, Amy Byrick and Morten Rasmussen are also present. The entire call will last for around 50 minutes, including time for questions at the end.

Before we begin, I would like to remind you that the information presented during the call is unaudited and that management may make forward-looking statements. These statements are based on current expectations and beliefs and involve risks and uncertainties that could cause actual results to differ materially from those described in any forward-looking statements.

With this, I'll now hand you over to our CEO, Ester Baiget. Ester, please.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot